BHV-3000 (Rimegepant) Oral Disintegrating Tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BHV-3000 (Rimegepant) Oral Disintegrating Tablet, covering 2024-05-16 to 2024-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders [Phase 3]